Why FDA Form 483 Matters in 2025? As FDA inspection activities intensify post-pandemic,  FDA Form 483 (also known as Inspectional Observations) has regained prominence as a critical regulatory checkpoint. Inconsistent data integrity, incomplete documentation, and procedural gaps remain among the top-cited issues. For pharmaceutical, biologics, and device companies alike, a single observation can have serious [...]